SpaceX Stock Price Prediction: What Analysts Actually Say vs. What the Market Is Paying

On its third day of Nasdaq trading, SpaceX stock hit an intraday high of $225.64. The highest 12-month analyst price target on all of Wall Street at that point was $227. In roughly 48 hours of public life as a stock, SPCX had nearly lapped the most bullish professional forecast available. The same company has a Morningstar fair value estimate of $63. The Wall Street consensus average sits at $164. The stock closed June 16 at $201.80. The gap between all these numbers is not normal, and that gap is arguably the most useful thing you can understand about SPCX right now.

Let's break down what each named analyst actually thinks this stock is worth, why a $164 spread from most bearish to most bullish reflects something unusual even by the standards of big IPOs, and what the current price mathematically requires you to believe about SpaceX's next five years.

SPCX Stock Price, IPO Valuation and Key Financials

Before the analyst opinions, here is the baseline.

Source: SpaceX S-1 filing (May 2026), TradingView, Yahoo Finance, Investing.com. Data as of June 16, 2026.

The stock moved from $135 at IPO pricing to $225.64 intraday in three trading sessions. That is a 67% move from listing price, with no quarterly earnings report, no analyst upgrades from underwriting banks (still in their quiet period), and no fundamental change in the underlying business.

SpaceX Stock Price Targets: What Analysts Are Saying About SPCX

Here is the full breakdown of analysts coverage on SPCX Stock:

Source: Oppenheimer via TheStreet (June 2026); CFRA via Kiplinger; Morningstar via TechTimes; Consensus data via Investing.com, StockAnalysis.com as of June 15, 2026. 

A few things stand out here.

Oppenheimer's Timothy Horan was the first analyst outside the IPO's underwriting syndicate to publish a formal rating. His $190 Outperform rests on a single argument: no publicly traded company does what SpaceX does across three verticals simultaneously. That may be true. It also didn't stop the market from surpassing his target within 48 hours.

Morningstar's $63 is the number that gets less attention than it deserves. Nicolas Owens didn't arrive at $63 carelessly. He ran a probability-weighted discounted cash flow model on SpaceX's projected cash flows, the same methodology used to value every other major company on earth. His conclusion is that the fundamental business, with normal discount rates applied, is worth $63 per share. The current price of ~$200 puts roughly $137 per share in the "market believes things Owens's model doesn't" category.

CFRA's Keith Snyder is the only formal Sell rating on the street. His $115 target, as per Kiplinger, attributes the view to SpaceX's "dependence on unproven outcomes including Starship commercialization, orbital AI compute, and xAI monetization"; the market, he argued, assigns too much to optionality and not enough discount to execution risk.

Wedbush's Dan Ives was publicly bullish on the IPO day, calling it "an important moment for the broader tech sector" in a note to clients. Wedbush had not published a formal 12-month price target for SPCX as of this writing. His commentary tells you the direction of his conviction, not the number behind it.

The underwriting banks: Goldman Sachs, Morgan Stanley, Bank of America, Citigroup, JPMorgan, remain in their mandatory quiet period. None of them can publish independent research on a stock they helped price. Their coverage, when it comes, will likely be the biggest single event for the analyst consensus.

The 260% Spread: Why SpaceX Stock Price Targets Are So Far Apart

Take Morningstar's $63 and the highest published target of $227. The percentage gap between those two numbers is approximately 260%.

Apple analysts normally sit within 10-15% of each other. Tesla, which has attracted more analyst disagreement than almost any company in the S&P 500, carries a spread of around 40-50%. A 260% spread on a company that only went public five days ago is a different category.

This isn't sloppiness. The analysts have access to the same S-1 filing. They've read the same $18.7 billion revenue figure, the same $4.9 billion net loss, the same Starlink subscriber data. Their disagreement is not about the facts. It is about which version of SpaceX's future to price. Morningstar is pricing what the company can deliver with standard discount rates and no credit for speculative revenue. The $227 camp is pricing a company that becomes the dominant infrastructure platform of the AI and space era.

Those are not slightly different assumptions. They are different companies.

The other thing worth noting: SPCX touched $225.64 intraday on June 16. The highest analyst 12-month target was $227. The market came within $1.36 of the single most bullish professional estimate on the street, in just two trading sessions. When that happens, analyst models aren't driving the price anymore. Supply mechanics are. Something worth understanding before drawing conclusions about where the stock "should" be.

The Reverse Valuation: What SpaceX Must Deliver to Justify Its Current Valuation

Most coverage asks "what is SpaceX worth?" There's a more useful question: at ~$2.6 trillion today, what does SpaceX actually need to deliver for current buyers to break even?

Think of it like buying a flat in a developing colony. The flat, based on what exists today, is worth ₹50 lakhs. But you're paying ₹1.5 crore because the seller shows you three plans on paper; a metro station, a mall, and a corporate park, all "under development." Before writing the cheque, the honest question is: what's the probability all three actually come through? If even one gets delayed by five years, you've overpaid significantly.

SpaceX at $2.6 trillion is that scenario, at global scale. Here is what SpaceX's revenue needs to reach by 2030-31, at different future valuation multiples, for today's price to hold up.

Note: Revenue required figures are illustrative, derived from dividing the current market cap (~$2.6 trillion) by the respective P/S multiple. Goldman Sachs ~$470 billion 2030 revenue projection cited from CNBC and Yahoo Finance reports. Morgan Stanley has separately projected $3.4 trillion in SpaceX revenue by 2040, as per CNBC.

The math is technically workable. But it needs two things to be true at the same time. Goldman Sachs's $470 billion 2030 forecast has to materialize and Goldman's own model requires xAI revenue to grow roughly 100x from its current base to power that number. And SpaceX has to sustain a 10x or higher revenue multiple in 2030, which isn't guaranteed as AI competition intensifies and the company's growth rate normalizes.

Both assumptions need to work. Neither is obviously wrong. But neither is obviously right, either.

The Three Big Bets Behind SpaceX Stock: Starlink, Starship and xAI

Buying SPCX at $200 is not a single bet on a single company. It's three separate bets inside one ticker.

Starlink holding its lead. This is the only profitable part of SpaceX right now. $11.4 billion in 2025 revenue, $4.4 billion in operating profit, a 63% adjusted EBITDA margin, and had around 10.3 million subscribers across 164 countries, territories and markets as of March 31, 2026. The trajectory is genuinely strong. The risk is competition as Amazon's Project Kuiper is scaling, and Starlink's move into lower-income markets could compress ARPU (revenue per subscriber) over time.

Starship commercializing. This is the biggest variance in the entire bull case. If Starship reaches operational scale, it reduces launch costs by an order of magnitude and unlocks orbital cargo, tourism, and eventually deep-space missions as real revenue lines. Goldman's model appears to price this in. If timelines slip, which they have before, revenue projections across the street move with them.

xAI becoming a real business. xAI posted a $6.36 billion operating loss in 2025. All eleven of its co-founders had departed by the end of March 2026. Before the IPO, Elon Musk publicly said xAI was "not built right the first time." The $60 billion Cursor acquisition is the response to that. Whether Cursor's 7 million developer users translate into the $300+ billion in AI revenue that Goldman's 2030 model requires is the most open question in the entire SpaceX investment thesis.

If all three bets work, Goldman Sachs's forecast is reasonable and today's buyers may look prescient a decade from now. If even one materially misses, the current price is difficult to defend on fundamentals alone.

What Could Push SpaceX Stock Higher In The Near Term

Two structural events on the calendar could drive SPCX upward independent of business results.

Nasdaq 100 inclusion, expected around early July 2026. Nasdaq changed its fast-track rules in May 2026 to allow large IPOs to join the Nasdaq 100 within approximately 15 trading days of listing. That window opens around July 2-3. Every fund tracking the Nasdaq 100, including QQQ and its global equivalents, must buy SPCX in proportion to its index weight. BNP Paribas estimated this could generate approximately $8 billion in forced passive buying within the first month of inclusion, as per the Investing.com IPO guide. That is mechanical demand, not judgment-based demand.

First public earnings on September 2, 2026. This is the first hard fundamental checkpoint. It's also the moment underwriting banks come off their quiet period and start publishing independent research. Goldman Sachs, Morgan Stanley, and JPMorgan collectively covering SPCX will move the consensus from six analysts to potentially fifteen or twenty, which changes how institutional allocators treat the stock.

What Could Prove the Bear Case on SpaceX Stock Wrong?

Three scenarios would seriously challenge the caution built into the $63-$164 analyst range.

1. Starlink growth accelerating faster than expected and xAI showing narrowing losses in Q2 2026 would give analysts at the underwriting banks room to initiate coverage with aggressive targets. One strong quarterly print from a company this closely watched rewrites the trajectory story.
2. The Cursor acquisition moving faster than anyone expected, showing early ARPU data for its 7 million developers and demonstrating actual xAI revenue acceleration, would change the math on the AI segment. A $60 billion spend is a lot easier to justify if it's visibly working by Q3 2026.
3. And a confirmed Tesla-SpaceX merger, which Wedbush's Dan Ives has put at 80-90% probability for first-half 2027, would require the entire bull case to be redrafted. Not confirmed. Still firmly in the rumor category. But enough analysts have started treating it as a live scenario that it belongs in any honest accounting of what could change.

Is SpaceX Stock Overvalued After Its IPO? Our View

The numbers at $200 per share do not independently justify the current price. SpaceX lost $4.9 billion in 2025 and $4.28 billion in Q1 2026 alone. Its only profitable segment, Starlink, is excellent, but even a generous standalone valuation for Starlink produces a fraction of the current market cap. The majority of the price rests on xAI, the segment that lost the most money, saw all eleven co-founders leave, and is now betting $60 billion on an AI coding tool that has lost market share.

That does not mean the price falls. The same tight float that took SPCX from $135 to $225 in two sessions can sustain elevated prices well past where fundamentals would place it. Passive buying from Nasdaq 100 inclusion alone could absorb billions in near-term selling. Amazon traded at valuations in 1999 that looked absurd on any model and it took years, but eventually the business grew large enough to justify those prices. SpaceX has a plausible path to doing the same.

But the gap between $63 and $227 isn't analyst noise. It's a genuine disagreement about which company SpaceX will be in five years. One version is of Starlink sustaining its lead, Starship delivering on time, xAI recovering under new product direction which makes today's price defensible in retrospect. The other version being any one of those three bets coming in materially short, does not. September 2 is the first real data point. Everything before that, including analyst targets and price action, is the market trying to price a story that hasn't been told yet.